CDKN2A and cervical carcinoma: Our data not only provided insights into the role of P16INK4A in cervical cancer, but also suggested that targeting P16INK4 expression may act as a novel experimental radiosensitizer with a potential anti-cancer function for developing effective therapeutic strategies against cervical cancer.